海藻糖检测试剂盒Trehalose Assay Kit Trehalose Assay Kit 货号:K-TREH Megazyme试剂盒

海藻糖检测试剂盒Trehalose Assay Kit

英文名:Trehalose Assay Kit

货号:K-TREH

规格:100 assays (manual) / 1000 assays (microplate)

市场价: 4452

The Trehalose test kit is a simple method for the rapid and reliable measurement and analysis of trehalose in foods, beverages and other materials.

Suitable for manual, auto-analyser and microplate formats.

UV-method for the determination of Trehalose and
D-Glucose in foodstuffs, beverages, and other materials

Principle:
(trehalase)
(1) Trehalose + H2O → D-glucose

(hexokinase)
(2) D-Glucose + ATP → G-6-P + ADP

(glucose-6-phosphate dehydrogenase)
(3) G-6-P + NADP+ → gluconate-6-phosphate + NADPH + H+

Kit size: 100 assays (manual) / 1000 (microplate)
/ 1100 (auto-analyser)
Method: Spectrophotometric at 340 nm
Reaction time: ~ 8 min
Detection limit: 37.5 mg/L
Application examples:
Honey, mushrooms, bread, beer, seafood (e.g. lobster and shrimp),
fruit juices, purees and fillings, nutrition bars, surimi, dehydrated fruits
and vegetables, fruit products, white chocolate, sports drinks, dairy
products, egg products, soups and sauces, confectionery, chewing gum,
cosmetics, pharmaceuticals and other materials (e.g. biological cultures,
samples, etc.)
Method recognition: Novel method

Advantages

  • Only enzymatic kit available
  • Very cost effective
  • All reagents stable for > 2 years after preparation
  • Very rapid reaction
  • Mega-Calc™ software tool is available from our website for hassle-free raw data processing
  • Standard included
  • Suitable for manual, microplate and auto-analyser formats

 

 Q1. Should the pH of the sample be adjusted even for samples in acidic media?

The pH of the assay solution after the sample is added should be the same as that of the assay buffer that is supplied with the kit.
Low sample volumes (e.g. 0.1 mL) are not likely to affect the pH of the assay solution and therefore may not require pH adjustment.
Samples above 0.1 mL are more likely to affect the pH of the assay solution and therefore the pH of these samples should be adjusted as described in the data booklet, prior to addition to the assay.

Q2. Sometimes a negative absorbance change is obtained for the blank samples, is this normal? Should the real value (negative absorbance change) or “0” be used in the calculation of results?

Sometimes the addition of the last assay component can cause a small negative absorbance change in the blank samples due to a dilution effect and in such cases it is recommended that the real absorbance values be used in the calculation of results.

Q3. There is an issue with the performance of the kit; the results are not as expected.

If you suspect that the Megazyme test kit is not performing as expected such that expected results are not obtained please do the following:

  1. Ensure that you have tested the standard sample that is supplied with the Megazyme test kit.
  2. Send the results of the kit standard, blank samples and the results obtained for your sample, in the relevant MegaCalc spreadsheet (if available) to Megazyme (cs@megazyme.com). Where available the relevant MegaCalc spreadsheet can be downloaded from where the product appears on the Megazyme website.
  3. State the kit lot number being used (this is found on the outside of the kit box).
  4. State which assay format was used (refer to the relevant page in the kit booklet if necessary).
  5. State exact details of any modifications to the standard procedure that is provided by Megazyme.
  6. State the sample type and describe the sample preparation steps if applicable.

Q4. How can I work out how much sample to extract and what dilution of my sample should be used in the kit assay?

Where the amount of analyte in a liquid sample is unknown, it is recommended that a range of sample dilutions are prepared with the aim of obtaining an absorbance change in the assay that is within the linear range.
Where solid samples are analysed, the weight of sample per volume of water used for sample extraction/preparation can be altered to suit, as can the dilution of the extracted sample prior to the addition of the assay, as per liquid samples.

Q5. I have some doubts about the appearance/quality of a kit component what should be done?

If there are any concerns with any kit components, the first thing to do is to test the standard sample (control sample) that is supplied with the kit and ensure that the expected value (within the accepted variation) is obtained before testing any precious samples. This must be done using the procedure provided in the kit booklet without any modifications to the procedure. If there are still doubts about the results using the standard sample in the kit then send example results in the MegaCalc spread sheet to your product supplier (Megazyme or your local Megazyme distributor).

Q6. How much sample should be used for the clarification/extraction of my sample?

The volume/weight of sample and total volume of the extract can be modified to suit the sample. This will ultimately be dictated by the amount of analyte of interest in the sample and may require empirical determination. For low levels of analyte the sample:extract volume ratio can be increased (i.e. increase the sample and/or decrease the total extraction volume).

Alternatively, for samples with low concentrations of analyte, a larger sample volume can be added to the kit assay. When altering the sample volume adjust the distilled water volume added to the assay accordingly so that the total assay volume is not altered.

Q8. Can the test kit be used to measure biological fluids and what sample preparation method should be used?

The kit assay may work for biological fluids assuming that inositol is present above the limit of detection for the kit after any sample preparation (if required). Centrifugation of the samples and use of the supernatant directly in the kit assay (with appropriate dilution in distilled water) may be sufficient. However, if required a more stringent sample preparation method may be required and examples are provided at the following link:http://www.megazyme.com/docs/analytical-applications-downloads/biological_samples_111109.pdf?sfvrsn=2

The test kit has not been tested using biological fluids as samples because it is not marketed or registered as a medical device. This will therefore require your own validation.

Q9. Can the manual assay format be scaled down to a 96-well microplate format?

The majority of the Megazyme test kits are developed to work in cuvettes using the manual assay format, however the assay can be converted for use in a 96-well microplate format. To do this the assay volumes for the manual cuvette format are reduced by 10-fold. The calculation of results for the manual assay format uses a 1 cm path-length, however the path-length in the microplate is not 1 cm and therefore the MegaCalc spreadsheet or the calculation provided in the kit booklet for the manual format cannot be used for the micropalate format unless the microplate reader being used can.

There a 3 main methods for calculation of results using the microplate format:

  1. The easiest method is to use a microplate reader that has a path-length conversion capability (i.e. the microplater reader can detect the path-length of each well and convert the individual readings to a 1 cm path-length). This will allow values to be calculated using the MegaCalc calculation software which can be found where the product is located on the Megazyme website.
  2. Perform a standard curve of the analyte on each microplate that contains test samples and calculate the result of the test samples from the calibration curve (concentration of analyte versus absorbance).
  3. Perform a standard curve of the analyte in both the cuvette format (i.e. with a 1 cm path-length) and the 96-well microplate format and use these results to obtain a mean conversion factor between the cuvette values and the microplate values. Subsequent assays in the microplate format can then be converted from the calculated conversion factor.

Q10. Can the sensitivity of the kit assay be increased?

For samples with low concentrations of analyte the sample volume used in the kit assay can be increased to increase sensitivity. When doing this the water volume is adjusted to retain the same final assay volume. This is critical for the manual assay format because the assay volume and sample volume are used in the calculation of results.

Q11. When using this kit for quantitative analysis what level of accuracy and repeatability can be expected?

The test kit is extremely accurate – at Megazyme the quality control criteria for accuracy and repeatability is to be within 2% of the expected value using pure analytes.

However, the level of accuracy is obviously analyst and sample dependent.

Q12. Is it possible to add a larger volume then 2 μL of enzyme to the microplate assay? In some instances 2 μL can be difficult to pipette manually.

Yes, instead of adding 2 μL of enzyme suspension an alternative is to dilute the enzyme and add a larger volume to the microplate assay.

Dilute the assay buffer 10-fold with distilled water and use this as the diluent to dilute an aliquot of the enzyme suspension also by 10-fold. Instead of 2 μL, use 20 μL of the diluted enzyme in the microplate assay.

Q13. Must the minimum absorbance change for a sample always be at least 0.1?

No. The 0.1 change of absorbance is only a recommendation. The lowest acceptable change in absorbance can is dictated by the analyst and equipment (i.e. pipettes and spectrophotometer) and therefore can be can be determined by the user. With accurate pipetting, absorbance changes as low as 0.02 can be used accurately.
If a change in absorbance above 0.1 is required but cannot be achieved due to low concentrations of analyte in a sample, this can be overcome by using a larger sample volume in the assay to increase the absorbance change and thereby increase sensitivity of the assay. When doing this the increased volume of the sample should be subtracted from the distilled water volume that is added to the assay so that the total assay volume is unaltered. The increase sample volume should also be accounted for when calculating final results. 

Q14. Can the sensitivity of the kit assay be increased?

Yes. Samples with the lower concentrations of analyte will generate a lower absorbance change. For samples with low concentrations of analyte, a larger sample volume can be used in the assay to increase the absorbance change and thereby increase sensitivity of the assay. When doing this the increased volume of the sample should be subtracted from the distilled water volume that is added to the assay so that the total assay volume is unaltered. The increase sample volume should also be accounted for when calculating final results.

重点推介:FUJIFILM Wako海藻糖二水合物Trehalose Dihydrate(206-18455)

重点推介:FUJIFILM Wako海藻糖二水合物Trehalose Dihydrate(206-18455)

海藻糖du特的生物学特性,使得其在医药领域中已得到广泛应用,主要用作生物制剂的冻干保护剂、单抗注射液的蛋白保护剂,以及血液制品的保存保护液,发挥稳定生物膜和蛋白质结构的功效。同蔗糖等一般糖类相比,具有du特的优势,在疫苗、诊断试剂和其他生物制品中的应用越来越广泛。

1、海藻糖在疫苗中的应用也越来越多,海藻糖替换血清白蛋白作为保护剂,使得疫苗产品的稳定性增加不少,这使得很多疫苗不但可以常温条件保存,降低了冷链运输等高昂成本,更重要的是可以防止因血源污染而引起乙肝、艾滋病等致命疾病的传播。

2、海藻糖对酶和蛋白的保护作用已得到广泛验证。有文献报道在某些诊断试剂盒的酶结合物稀释液中添加8-12wt%的海藻糖,利用稳定剂海藻糖能使酶结合物稀释液保持稳定的功能,来维持试剂盒的稳定性。还有一些数据显示,加入海藻糖后,酶标抗体在37℃4d后活性无明显变化,而不加稳定剂海藻糖的酶标抗体活性几乎wan全丧失。

海藻糖二水合物(Trehalose dihydrate),由两个葡萄糖分子以1,1-糖苷键构成的非还原性糖,有3种异构体即海藻糖(αα)、异海藻糖(ββ)和新海藻糖(αβ),并对多种生物活性物质具有非特异性保护作用。海藻糖在自然界中许多可食用动植物及微生物体内都广泛存在,如人们日常生活中食用的蘑菇类、海藻类、豆类、虾、面包、啤酒及酵母发酵食品中都有含量较高的海藻糖。下面让我们一起来看看FUJIFILM Wako海藻糖二水合物的产品属性吧!

CAS No.6138-23-4

纯度:98.0+% (HPLC)

分子式:C12H22O112H2O

分子量:378.33

等级:Wako Special Grade

储存条件:室温

上海金畔生物科技有限公司重点推介FUJIFILM Wako海藻糖二水合物Trehalose Dihydrate(206-18455),欢迎选购!

 

22:0 Trehalose

上海金畔生物科技有限公司提供22:0 Trehalose ,欢迎访问官网了解更多产品信息和订购。
22:0 Trehalose

详情介绍

Synonym: 22:0 Trehalose; D-(+)-trehalose 6,6'-dibehenate

IUPAC/Chemical Name: ((2R,2'R,3S,3'S,4S,4'S,5R,5'R,6R,6'R)-oxybis(3,4,5-trihydroxytetrahydro-2H-pyran-6,2-diyl))bis(methylene) didocosanoate

InChi Key: ZLJJDBSDZSZVTF-LXOQPCSCSA-N

InChi Code: InChI=1S/C56H106O13/c1-3-5-7-9-11-13-15-17-19-21-23-25-27-29-31-33-35-37-39-41-47(57)65-43-45-49(59)51(61)53(63)55(67-45)69-56-54(64)52(62)50(60)46(68-56)44-66-48(58)42-40-38-36-34-32-30-28-26-24-22-20-18-16-14-12-10-8-6-4-2/h45-46,49-56,59-64H,3-44H2,1-2H3/t45-,46-,49-,50-,51+,52+,53-,54-,55-,56-/m1/s1

SMILES Code: O[C@H]([C@@H](COC(CCCCCCCCCCCCCCCCCCCCC)=O)O[C@H](O[C@@H](O[C@@H]([C@H]([C@@H]1O)O)COC(CCCCCCCCCCCCCCCCCCCCC)=O)[C@@H]1O)[C@@H]2O)[C@@H]2O

Appearance: Solid powder

Purity: >98% (or refer to the Certificate of Analysis)

Shipping Condition: Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.

Storage Condition: Dry, dark and at 0 – 4 C for short term (days to weeks) or -20 C for long term (months to years).

Solubility: Soluble in DMSO

Shelf Life: >3 years if stored properly

Drug Formulation: This drug may be formulated in DMSO

Stock Solution Storage: 0 – 4 C for short term (days to weeks), or -20 C for long term (months).

HS Tariff Code: 2934.99.9001

22:0 Trehalose

MedKoo 是超高质量的实验室药物供应商。它于2009年由获得博士学位的Qingqi Chen博士创立。北京大学合成化学专业,并在约翰内斯-开普勒大学林茨(与 Heinz Falk 博士)、内华达里诺大学(与 David Lightner 博士)和不列颠哥伦比亚大学(与 David Dolphin 博士)接受博士后培训。

荧光素FITC标记海藻糖 (FITC-Trehalose),D-Trehalose anhydrous 化学式 C12H22O11 分子量 378.33

中文名 海藻糖 

外文名 D-Trehalose haihydrous 

化学式 C12H22O11 

分子量 378.33

CAS登录号 99-20-7 

EINECS登录号 202-739-6 

熔    点 214 ℃ 

沸    点 397.76 ℃ 

水溶性 68.9g/100g水(25℃) 

 密    度 1.512 g/cm³  

简介

海藻糖有3种光学异构体,分别是α,α-海藻糖(蘑菇糖,Mushroom Sugar)、α,β-海藻糖(新海藻糖,Neotrehalose)和β,β-海藻糖(异海藻糖,Isotrehalose)。其中只有α,α-海藻糖在自然界中以游离状态存在,即为通常所说的海藻糖,广泛存在于各种生物体中,包括细菌、酵母、真菌和藻类以及一些昆虫、无脊椎动物和植物中,尤其在酵母中含量较多,面包和啤酒等发酵食品及虾类等也含有海藻糖。α,β-型和β,β-型在自然界中很少见,仅在蜂蜜和蜂王浆中发现了少量的α,β-型海藻糖,α,β-型和β,β-型这两种海藻糖可以化学合成。 

海藻糖为体内有益肠道细菌–双歧杆菌的增殖因子,可改善肠道微生态环境,加强胃肠道消化吸收功能,有效排除体内毒素,增强机体免疫抗病能力,研究还证明海藻糖具有较强的抗辐射作用。

荧光素FITC标记海藻糖 (FITC-Trehalose),D-Trehalose haihydrous   化学式 C12H22O11   分子量 378.33

用途:科研

状态:固体/粉末

产地:上海

储存时间:1年

保存:冷藏

储藏条件:-20℃

购买须知:

1.关于颜色

产品因不同产品的分子量不同,产品性状和颜色会有差别。

2.关于客服

如您的咨询没能及时回复,可能是当时咨询量过大或是系统故障。

我们将提供售后服务。

3.关于发货

我们的合作快递公司有顺丰、圆通、申通、韵达。

仅用于用于科研,不能用于人体试验(zyl 2022.04.14)